BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38504536)

  • 1. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
    Li R; Yang H; Xue Y; Xianqin L
    J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effect and component analysis of Chaihu Qingwen granules.
    Zhou Y; Li QX; Liao ZZ; Liu Y; Ouyang Y; Jiang WJ; Tang MT; Hu JF; Zhang W
    J Ethnopharmacol; 2023 Dec; 317():116763. PubMed ID: 37315646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
    Wang B; Wang J; Lu D; Qi N; Liu Q
    J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
    Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
    J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydropalmatine induces the polarization of M1 macrophages to M2 to relieve limb ischemia-reperfusion-induced lung injury via inhibiting the TLR4/NF-κB/NLRP3 signaling pathway.
    Wen H; Lu D; Chen H; Zhu Y; Xie Q; Zhang Z; Wu Z
    Drug Dev Res; 2022 Sep; 83(6):1362-1372. PubMed ID: 35976115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-206-3p alleviates LPS-induced acute lung injury via inhibiting inflammation and pyroptosis through modulating TLR4/NF-κB/NLRP3 pathway.
    Chen M; Zhang J; Huang H; Wang Z; Gao Y; Liu J
    Sci Rep; 2024 May; 14(1):11860. PubMed ID: 38789583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of lung and intestine combination therapy in treatment of acute lung injury by inhibiting inflammatory response based on NF-κB/NLRP3 signaling pathway and alveolar macrophage activation].
    Kou YL; Wang WB; Yan SG; Li JT; Shi J; Hui Y
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):151-158. PubMed ID: 35178922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway.
    Miao J; Shen J; Yan C; Ren J; Liu H; Qiao Y; Li Q
    Phytomedicine; 2022 Sep; 104():154290. PubMed ID: 35793597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
    Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
    J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
    Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
    Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
    Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
    Front Immunol; 2022; 13():846384. PubMed ID: 35281058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
    Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
    J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
    Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
    J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of heat shock transcription factor 1 on acute lung injury in septic rats by regulating NOD-like receptor protein 3 inflammasome activation].
    Jin C; Zhang W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1167-1172. PubMed ID: 36567560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin inhibits inflammation of lipopolysaccharide-induced acute lung injury toll like receptor-4/myeloid differentiation primary response 88/nuclear factor-kappa B signaling pathway.
    Changle Z; Cuiling F; Feng F; Xiaoqin Y; Guishu W; Liangtian S; Jiakun Z
    J Tradit Chin Med; 2022 Apr; 42(2):200-212. PubMed ID: 35473340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
    Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
    Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Butyrate Inhibits the Inflammation of Lipopolysaccharide-Induced Acute Lung Injury in Mice by Regulating the Toll-Like Receptor 4/Nuclear Factor κB Signaling Pathway.
    Liu J; Chang G; Huang J; Wang Y; Ma N; Roy AC; Shen X
    J Agric Food Chem; 2019 Feb; 67(6):1674-1682. PubMed ID: 30661349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.